Biopharma Industry Sharply Divided Over Supreme Court Antibody Patent Brawl

 
• By Brenda Sandburg

Big biologic makers line up on opposite sides of dispute between Amgen and Sanofi over whether Amgen’s Repatha patents cover analogous antibodies with the same functional characteristics.

Supreme building closeup
Supreme Court to hear high stakes patent case involving monoclonal antibodies and genus claims • Source: Shutterstock

More from Legal & IP

More from Pink Sheet